1. Protein Tyrosine Kinase/RTK
  2. VEGFR
  3. VEGFR3/Flt-4 Inhibitors

VEGFR3/Flt-4 Inhibitors

VEGFR1/Flt-1

VEGFR2/KDR/Flk-1

VEGFR3/Flt-4

Your Search Returned No Results.

Sorry. There is currently no product that acts on isoform VEGFR3/Flt-4 together.

Please try each isoform separately.

VEGFR3/Flt-4 Specific Inhibitors
Product Name VEGFR3/Flt-4 VEGFR1/Flt-1 VEGFR2/KDR/Flk-1 VEGFR3/Flt-4 Selectivity Purity
SAR131675
VEGFR3, IC50: 23 nM
    Selective Inhibitor 99.80%
Sorafenib
VEGFR3, IC50: 20 nM
 
VEGFR2, IC50: 90 nM
Pan Inhibitor 99.92%
Nintedanib
VEGFR3, IC50: 13 nM
VEGFR1, IC50: 34 nM
VEGFR2, IC50: 13 nM
Pan Inhibitor 99.97%
Regorafenib
VEGFR3, IC50: 46 nM
VEGFR1, IC50: 13 nM
VEGFR2, IC50: 4.2 nM
Pan Inhibitor 99.96%
ODM-203
VEGFR3, IC50: 5 nM
VEGFR1, IC50: 26 nM
VEGFR2, IC50: 9 nM
Pan Inhibitor
Sorafenib Tosylate
VEGFR3, IC50: 20 nM
 
VEGFR2, IC50: 90 nM
Pan Inhibitor 99.53%
Cediranib
Flt-4, IC50: 3 nM
Flt-1, IC50: 5 nM
KDR, IC50: 1 nM
Pan Inhibitor 99.58%
Lucitanib
VEGFR3, IC50: 10 nM
VEGFR1, IC50: 7 nM
VEGFR2, IC50: 25 nM
Pan Inhibitor 98.24%
Sitravatinib
VEGFR3, IC50: 2 nM
VEGFR1, IC50: 6 nM
VEGFR2, IC50: 5 nM
Pan Inhibitor 99.85%
Tivozanib
VEGFR3, IC50: 15 nM
VEGFR1, IC50: 30 nM
VEGFR2, IC50: 6.5 nM
Pan Inhibitor 99.52%
Gandotinib
Flt-4, IC50: 25 nM
 
KDR, IC50: 109 nM
Pan Inhibitor 99.96%
Nintedanib esylate
VEGFR3, IC50: 13 nM
VEGFR1, IC50: 34 nM
VEGFR2, IC50: 13 nM
Pan Inhibitor 99.95%
5Z-7-Oxozeaenol
VEGFR-3, IC50: 110 nM
 
VEGFR-2, IC50: 52 nM
Pan Inhibitor >99.0%
Regorafenib Hydrochloride
VEGFR3, IC50: 46 nM
VEGFR1, IC50: 13 nM
VEGFR2, IC50: 4.2 nM
Pan Inhibitor 98.65%
Motesanib
VEGFR3, IC50: 6 nM
VEGFR1, IC50: 2 nM
VEGFR2, IC50: 3 nM
Pan Inhibitor 99.75%
Fruquintinib
VEGFR3, IC50: 0.5 nM
VEGFR1, IC50: 33 nM
VEGFR2, IC50: 35 nM
Pan Inhibitor 99.93%
Pazopanib Hydrochloride
VEGFR3, IC50: 47 nM
VEGFR1, IC50: 10 nM
VEGFR2, IC50: 30 nM
Pan Inhibitor 99.92%
Tesevatinib
Flt-4, IC50: 8.7 nM
 
KDR, IC50: 1.5 nM
Pan Inhibitor 99.21%
Regorafenib monohydrate
VEGFR3, IC50: 46 nM
VEGFR1, IC50: 13 nM
VEGFR2, IC50: 4.2 nM
Pan Inhibitor 99.94%
TAK-593
VEGFR3, IC50: 1.1 nM
VEGFR1, IC50: 3.2 nM
VEGFR2, IC50: 0.95 nM
Pan Inhibitor 99.62%
Telatinib
VEGFR3, IC50: 4 nM
 
VEGFR2, IC50: 6 nM
Pan Inhibitor 99.49%
Motesanib Diphosphate
VEGFR3, IC50: 6 nM
VEGFR1, IC50: 2 nM
VEGFR2, IC50: 3 nM
Pan Inhibitor 99.64%
Cediranib maleate
Flt-4, IC50: 3 nM
Flt-1, IC50: 5 nM
KDR, IC50: 1 nM
Pan Inhibitor 96.67%
NVP-ACC789
VEGFR-3, IC50: 0.18 μM
VEGFR-1, IC50: 0.38 μM
VEGFR-2, IC50: 0.02 μM
mVEGFR-2, IC50: 0.23 μM
Pan Inhibitor 99.58%
NVP-BAW2881
VEGFR3, IC50: 420 nM
VEGFR1, IC50: 820 nM
VEGFR2, IC50: 9 nM
Pan Inhibitor 98.42%
KRN-633
VEGFR3, IC50: 125 nM
VEGFR1, IC50: 170 nM
VEGFR2, IC50: 160 nM
Pan Inhibitor 99.06%
Ilorasertib
VEGFR3, IC50: 43 nM
VEGFR1, IC50: 1 nM
VEGFR2, IC50: 2 nM
Pan Inhibitor
Sulfatinib
VEGFR3
VEGFR1
VEGFR2
default Inhibitor 98.34%
Chloropyramine hydrochloride
VEGFR-3
    default Inhibitor 99.30%